Chromosome Breakage Study, Bone Marrow
Maternal Screening, Sequential
MAML2 (11q21) Rearrangement, Mucoepidermoid Carcinoma (MEC), FISH, Tissue
Maternal Serum Screen, Alpha Fetoprotein (AFP) for Neural Tube Defect
PanCystPro Test for Pancreatic Cyst
Liver/Kidney Microsome Type 1 Antibodies
Wilms Tumor (WT-1), N-terminus by Immunohistochemistry
Primidone, Urine
Ehrlichia Antibody, Western Blot
Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) Genotyping
LDS
Sign up
Log in
LDS
/
Medical Tests
/
Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation Analysis in Bladder Cancer
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation Analysis in Bladder Cancer
Medical Test
References
Access to
Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation Analysis in Bladder Cancer
is restricted.
Sign up now
Loading...